Cost of Revenue of ENZO BIOCHEM INC from 31 Jul 2020 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
ENZO BIOCHEM INC quarterly and annual Cost of Revenue in USD history and change rate from 31 Jul 2020 to 30 Apr 2025.
  • ENZO BIOCHEM INC Cost of Revenue for the quarter ending 30 Apr 2025 was $3,755,000, a 12% decline year-over-year.
  • ENZO BIOCHEM INC annual Cost of Revenue for 2024 was $17,275,000, a 3.3% decline from 2023.
  • ENZO BIOCHEM INC annual Cost of Revenue for 2023 was $17,866,000, a 7% decline from 2022.
  • ENZO BIOCHEM INC annual Cost of Revenue for 2022 was $19,213,000, a 70% decline from 2021.
Source SEC data
View on sec.gov
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

ENZO BIOCHEM INC Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,755,000 -$534,000 -12% 01 Feb 2025 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q3 2024 $16,605,000 $3,681,000 -$670,000 -15% 01 Aug 2024 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 $17,275,000 $4,306,000 +$121,000 +2.9% 01 May 2024 31 Jul 2024 10-K 29 Oct 2024 2024 FY
Q1 2024 $17,154,000 $4,289,000 -$187,000 -4.2% 01 Feb 2024 30 Apr 2024 10-Q 16 Jun 2025 2025 Q3
Q4 2023 $17,341,000 $4,329,000 -$287,000 -6.2% 01 Nov 2023 31 Jan 2024 10-Q 13 Mar 2024 2024 Q2
Q3 2023 $17,628,000 $4,351,000 -$238,000 -5.2% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q2 2023 $17,866,000 $4,185,000 +$34,132,000 01 May 2023 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 $16,266,000 $4,476,000 -$11,573,000 -72% 01 Feb 2023 30 Apr 2023 10-Q 13 Jun 2024 2024 Q3
Q4 2022 $4,693,000 $4,616,000 -$13,222,000 -74% 01 Nov 2022 31 Jan 2023 10-Q 13 Mar 2024 2024 Q2
Q3 2022 $8,529,000 $4,589,000 -$10,684,000 -70% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q1
Q2 2022 $19,213,000 $29,947,000 01 May 2022 31 Jul 2022 10-K 03 Nov 2023 2023 FY
Q1 2022 $16,049,000 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023 2023 Q3
Q4 2021 $17,838,000 01 Nov 2021 31 Jan 2022 10-Q 20 Mar 2023 2023 Q2
Q3 2021 $15,273,000 01 Aug 2021 31 Oct 2021 10-Q 12 Dec 2022 2023 Q1

ENZO BIOCHEM INC Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $17,275,000 -$591,000 -3.3% 01 Aug 2023 31 Jul 2024 10-K 29 Oct 2024 2024 FY
2023 $17,866,000 -$1,347,000 -7% 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2022 $19,213,000 -$44,941,000 -70% 01 Aug 2021 31 Jul 2022 10-K 03 Nov 2023 2023 FY
2021 $64,154,000 +$11,903,000 +23% 01 Aug 2020 31 Jul 2021 10-K 14 Oct 2022 2022 FY
2020 $52,251,000 01 Aug 2019 31 Jul 2020 10-K 14 Oct 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.